Kay Ahn

3.6k citations

18 papers · 2.4k indexed · 1 hit paper · h-index 13

Impact in

Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
Pharmacology top 0.5%
- Cannabis and Cannabinoid Research

Papers in

Toxicology 3
- Forensic Toxicology and Drug Analysis 3
Pharmacology 10
- Cannabis and Cannabinoid Research 8

Co-authors: Benjamin F. Cravatt Michele K. McKinney Douglas S. Johnson Brandon Pabst Marya Liimatta Jessica Ward John E. Bleasdale Boris A. Chrunyk
Journals: Biochemistry (6 papers)Journal of Lipid Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)ACS Medicinal Chemistry Letters (1 paper)Journal of Biological Chemistry (1 paper)
Partner nations: United States Belgium France

In The Last Decade

Kay Ahn

17 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1 2010 · 723 citations

Peers

Countries citing papers authored by Kay Ahn

Since Specialization

Citations

This map shows the geographic impact of Kay Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Ahn more than expected).

Fields of papers citing papers by Kay Ahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Ahn. The network helps show where Kay Ahn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kay Ahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kay Ahn Line = papers co-authored together Kay Ahn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Remodeling oncogenic transcriptomes by small molecules targeting NONO Nature Chemical Biology ·Stefan G. Kathman, Seong Joo Koo, L Ue Yi, Hsuan-Lin Her, Steven M. Blue, Haoxin Li, Steffen Jaensch, Jarrett R. Remsberg, Kay Ahn, G Yeo, B.K. Ghosh, Benjamin F. Cravatt	2023	49
2	Discovery of an Allosteric, Inactive Conformation-Selective Inhibitor of Full-Length HPK1 Utilizing a Kinase Cascade Assay Biochemistry ·Weixue Wang, Laurence Mévellec, Yongfei Chai, Najwa Qotru Nada, Shagufta Rasool, Samantha J. Allen, Kelly Federowicz, Berthold Wroblowski, Jorge Vialard, Kay Ahn, Daniel J. Krosky	2021	12
3	Potent Phenylpyridine and Oxodihydrofuran Inhibitors of Cyclooxygenase-2: Optimization toward a Long Residence Time with Balanced Internal Energetics Biochemistry ·Gaochao Tian, Javier Suárez, Zhuming Zhang, Djurdjica Vukajlovic, Kay Ahn	2021	5
4	LC-MS/MS assay for the simultaneous quantitation of thromboxane B2 and prostaglandin E2 to evaluate cyclooxygenase inhibition in human whole blood SHILAP Revista de lepidopterología ·Yifan Shi, Heather E. Murrey, Kay Ahn, Naidong Weng, Shefali Patel	2020	0
5	Mechanistic Characterization of Long Residence Time Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2) Biochemistry ·Brandon Pabst, Kentaro Futatsugi, Qifang Li, Kay Ahn	2018	9
6	Discovery of Inactive Conformation-Selective Kinase Inhibitors by Utilizing Cascade Assays Biochemistry ·Weixue Wang, Daniel J. Krosky, Kay Ahn	2017	6
7	Mechanistic Characterization of a 2-Thioxanthine Myeloperoxidase Inhibitor and Selectivity Assessment Utilizing Click Chemistry–Activity-Based Protein Profiling Biochemistry ·Jessica Ward, Daniel Angúlo Movilla, Brandon Pabst, Philip A. Carpino, Roger B. Ruggeri, Gang Xing, Anna E Speers, Benjamin F. Cravatt, Kay Ahn	2013	27
8	The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH) Nuclear Medicine and Biology ·Marc B. Skaddan, Lei Zhang, Douglas S. Johnson, Aijun Zhu, Kenneth Zasadny, 陳餘鋆, Kyle Kuszpit, Rachid Mohammed Rachid, Fatih Mutlu Karada, Elizabeth Beck, Laigao Chen, Susan E. Drozda, Martha Dugan Rehm, Micah J. Niphakis, Benjamin F. Cravatt, Kay Ahn, Thomas Bocan, Anabella Villalobos	2012	25
9	Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver Journal of Lipid Research ·Angela Hall, Kou Kou, Zhouji Chen, Terri Pietka, Peter Andreas Schicker, Kevin Korenblat, Kyle Matthew Khellaf, Kay Ahn, Elisa Fabbrini, Samuel Klein, Bryan Goodwin, Brian N. Finck	2012	76
10	Deconstruction of Activity-Dependent Covalent Modification of Heme in Human Neutrophil Myeloperoxidase by Multistage Mass Spectrometry (MS⁴) Biochemistry ·Kieran F. Geoghegan, Alison H. Varghese, Xidong Feng, Yoga Budi Setya Nugraha, James J. Conboy, Roger B. Ruggeri, Kay Ahn, Daniel Angúlo Movilla, Sergey V. Filippov, Max Nab, Philip A. Carpino, Cristiano R. W. Guimarães, F.F. Vajdos	2012	15
11	Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain Journal of Pharmacology and Experimental Therapeutics ·Kay Ahn, Sarah E. Smith, Marya Liimatta, David Beidler, Nalini Sadagopan, David T. Dudley, Tim Young, Paul Wren, Yanhua Zhang, Steven Swaney, Keri Van Becelaere, Jacqueline L. Blankman, Daniel K. Nomura, Shobha Bhattachar, Cory M. Stiff, Tyzoon Nomanbhoy, Eranthie Weerapana, Douglas S. Johnson, Benjamin F. Cravatt	2011	191
12	SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1 Journal of Biological Chemistry ·Michelle Pacholec, John E. Bleasdale, Boris A. Chrunyk, David Cunningham, Declan Flynn, Robert S. Garofalo, David A. Griffith, Matt Griffor, モリスマーティン, Brandon Pabst, Xiayang Qiu, Brian J. Stockman, V. Thanabal, Alison E. Varghese, Jessica Ward, Jane M. Withka, Kay Ahn Hit paper breakdown →	2010	723
13	Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor ACS Medicinal Chemistry Letters ·Douglas S. Johnson, Cory M. Stiff, Scott E. Lazerwith, Suzanne R. Kesten, Teresa Barraza, Mark J. Morris, David Beidler, Marya Liimatta, Sarah E. Smith, David T. Dudley, Nalini Sadagopan, Shobha Bhattachar, S. Kesten, Tyzoon Nomanbhoy, Benjamin F. Cravatt, Kay Ahn	2010	148
14	Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain Chemistry & Biology ·Kay Ahn, Douglas S. Johnson, Mauro Mileni, David Beidler, Jonathan Z. Long, Michele K. McKinney, Eranthie Weerapana, Nalini Sadagopan, Marya Liimatta, Sarah E. Smith, Scott E. Lazerwith, Cory M. Stiff, Satwik Kamtekar, Keshab Bhattacharya, Zhang Yan-hua, Betty Marie Neff, Keri Van Becelaere, Raymond C. Stevens, Benjamin F. Cravatt	2009	373
15	Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH) Bioorganic & Medicinal Chemistry Letters ·Douglas S. Johnson, Kay Ahn, Suzanne R. Kesten, Scott E. Lazerwith, Yuntao Song, Mark J. Morris, Teresa Barraza, Tracy F. Gregory, Cory M. Stiff, James B. Dunbar, Marya Liimatta, David Beidler, Sarah E. Smith, Tyzoon Nomanbhoy, Benjamin F. Cravatt	2009	59
16	Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders Expert Opinion on Drug Discovery ·Kay Ahn, Douglas S. Johnson, Benjamin F. Cravatt	2009	151
17	Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System Chemical Reviews ·Kay Ahn, Michele K. McKinney, Benjamin F. Cravatt	2008	429
18	Structure-guided inhibitor design for human FAAH by interspecies active site conversion Proceedings of the National Academy of Sciences ·Mauro Mileni, Douglas S. Johnson, Zhigang Wang, Nuriye Semerci, Marya Liimatta, Brandon Pabst, Keshab Bhattacharya, Richard A. Nugent, Satwik Kamtekar, Benjamin F. Cravatt, Kay Ahn, Raymond C. Stevens	2008	127

About Kay Ahn

Kay Ahn is a scholar working on Toxicology, Pharmacology, Biochemistry, Geriatrics and Gerontology and Cellular and Molecular Neuroscience, having authored 18 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (8 papers), Pancreatic function and diabetes (5 papers), Forensic Toxicology and Drug Analysis (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Computational Drug Discovery Methods (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Pharmacological Receptor Mechanisms and Effects (2 papers) and Lipid metabolism and biosynthesis (2 papers). The work is most often cited by research in Geriatrics and Gerontology (526 citations), Pharmacology (1.2k citations), Toxicology (239 citations), Aging (64 citations) and Physiology (132 citations). Kay Ahn has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Benjamin F. Cravatt, Michele K. McKinney, Douglas S. Johnson, Brandon Pabst, Marya Liimatta, Jessica Ward, John E. Bleasdale, Boris A. Chrunyk, Robert S. Garofalo and David Cunningham. Their work appears in journals such as Biochemistry, Journal of Lipid Research, Journal of Pharmacology and Experimental Therapeutics, ACS Medicinal Chemistry Letters and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact